Source: Eur Respir J 2010; 36: 348
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Kang J.S.L., Cherian A., Gan S.H., Lee T.H., Lee K.C., Chee C.B.E., Doherty T.M., Wang Y.T., Seah G.T.. Strong purified protein derivative responses are associated with poor mycobacterium inhibition in latent TB. Eur Respir J 2010; 36: 348

Member's Comments

No comment yet.

Related content which might interest you: Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection Source: Eur Respir J 2010; 35: 619-626 Year: 2010 Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment Source: International Congress 2017 – Migrants and screening Year: 2017 IL-2 memory response after specific in vitro stimulation associates to latent tuberculosis infection Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis Year: 2009 Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 Correlation of Mycobacterium tuberculosis [not]-specific and non-specific quantitative T cell IFN-γ responses with mycobacillary load in a HIV-prevalent high burden setting Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008 IFN-gamma production in response to RD1 assays correlate with TST size and with the frequency of exposure to the index case in contacts recently exposed to mycobacterium tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 Characterization of the HBHA response in TB patients with or without HIV infection. Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Impact of Quantiferon TB Gold intensity response in active over latent tuberculosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012 RD1-epitopes response correlates with the time since first exposure in close contacts recently exposed to mycobacterium tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007 Improvement of interferon gama response to the combinations of 38kDa/CFP10, 38kDa/MPT-64, ESAT-6/MPT-64, CFP-10/ESAT-6 related to each single recombinants proteins of mycobacterium tuberculosis in individuals from endemic area for Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006 Low frequency of mycobacterium tuberculosis (MTB) transmission among close contacts of a highly symptomatic index case Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Comparison of two in vitro IFN-γ assays for detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to M. tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 363s Year: 2006